PocDoc is a technology company.
PocDoc has raised $3.0M across 1 funding round.
PocDoc has raised $3.0M in total across 1 funding round.
PocDoc has raised $3.0M in total across 1 funding round.
PocDoc's investors include Acton Capital Partners, MMC Ventures.
PocDoc is a UK-based digital diagnostics startup that develops smartphone-based home test kits for rapid screening of chronic diseases, primarily cardiovascular conditions. Its flagship product, the Healthy Heart Check, uses a finger-prick blood sample processed via the PocDoc app's patented HUESnap®AI platform to deliver clinical-grade results—including a full cholesterol profile, BMI score, heart age, and 10-year cardiovascular risk—in under 10 minutes, with seamless integration into NHS patient records.[1][2][3][4] PocDoc serves individuals seeking preventative health checks, as well as partners like the NHS, community pharmacies, and retailers, addressing the burden of preventable chronic diseases that cost the NHS £7.4 billion annually for cardiovascular issues alone.[1][4][5] The company aims to screen 150 million people in 10 years, saving lives and healthcare costs through accessible, at-home testing that shifts care from treatment to prevention.[1][4]
Growth has been rapid: output scaled from 3,000 tests monthly to 300,000 within 18 months, with expansion via NHS partnerships, pharmacies, and a new Cambridge hub opened in April 2024 for manufacturing and global exports.[1][5][7]
PocDoc was founded in 2019 (with formal incorporation around 2020) by Rory Cahill (likely the spokesperson), his wife Kiran, and Head of R&D Vladimir Gubala, driven by a shared passion for preventative care to detect chronic diseases early via smartphone technology.[1][7] The idea emerged from their belief in making diagnostics quick, easy, and phone-based, starting with cardiovascular screening to counter the UK's rising chronic disease burden.[1][4] Early traction came through NHS collaborations and community rollouts; by 2022, partnerships like one with Dears Pharmacy enabled CVD testing across Scotland, while integrations with the NHS app marked pivotal milestones in reducing GP appointment needs.[1][4][7][8] A collaborative, mission-driven culture in a single Cambridge facility has fueled scaling, with tens of thousands of users reached UK-wide from Cornwall to Edinburgh.[1][5]
PocDoc rides the preventative digital health wave, leveraging AI-driven point-of-care diagnostics amid rising chronic disease prevalence—80% preventable CVDs strain NHS resources amid clinician shortages.[1][4] Timing is ideal post-COVID, with telehealth and home testing booming (categorized in digital health, telehealth, Health IT by CB Insights), as analogue-to-digital NHS transitions demand scalable solutions like PocDoc's smartphone platform.[4][7] Market forces favoring it include NHS emphasis on three key shifts—prevention over treatment, digital over analogue, communities over hospitals—plus global export potential from its Cambridge hub.[4][5] PocDoc influences the ecosystem by freeing GP time (thousands of appointments), enabling mass screenings, and partnering with innovators like Health Innovation East, ABHI, and Medilink, while shortlisting for HSJ Digital Awards underscores its impact on population health.[5]
PocDoc is poised for explosive growth, expanding its test series beyond Healthy Heart Check to metabolic/renal diseases, deepening NHS/pharmacy integrations, and targeting global markets via its 2024 Cambridge hub—potentially adding hundreds of jobs.[1][5] Trends like AI diagnostics, preventative care mandates, and wearable health data will amplify its reach, especially as healthcare systems worldwide face similar chronic burdens. Its influence may evolve from UK pioneer to global leader in accessible screening, saving billions if it hits 150 million screens, though scaling manufacturing and regulatory approvals in new markets will be key tests. This smartphone revolution in diagnostics positions PocDoc to truly transform how we preempt chronic killers, echoing its founding mission.
PocDoc has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2023 | $3.0M Seed | Acton Capital Partners, MMC Ventures |